Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Fei-Fei Nan"'
Autor:
Yu Chang, Xiao‐Rui Fu, Meng Cui, Wei‐Ming Li, Lei Zhang, Xin Li, Ling Li, Zhen‐Chang Sun, Xu‐Dong Zhang, Zhao‐Ming Li, Xiao‐Yan You, Fei‐Fei Nan, Jing‐Jing Wu, Xin‐Hua Wang, Ming‐Zhi Zhang
Publikováno v:
Cancer Medicine, Vol 8, Iss 8, Pp 3892-3904 (2019)
Abstract Background Natural Killer T–Cell Lymphoma (NKTCL) is a subtype of Non‐Hodgkin's Lymphoma, and its morbidity is ranked the first of T‐Cell Lymphoma. Hippo signaling pathway is involved in the pathogenesis of tumors. However, the role of
Externí odkaz:
https://doaj.org/article/62191900ba694b99a5ee8b9a24ae47ba
Autor:
Jing-Jing Wu, Wen-Hua Wang, Meng Dong, Shan-Shan Ma, Xu-Dong Zhang, Li-Nan Zhu, Song-Tao Niu, Meng-Jie Ding, Jie-Ming Zhang, Lei Zhang, Xin Li, Ling Li, Zhen-Chang Sun, Xin-Hua Wang, Xiao-Rui Fu, Zhao-Ming Li, Yu Chang, Fei-Fei Nan, Jia-Qin Yan, Hui Yu, Xiao-Long Wu, Zhi-Yuan Zhou, Ming-Zhi Zhang
Publikováno v:
Investigational new drugs. 40(3)
Central nervous system lymphoma (CNSL) is an aggressive lymphoma. Orelabrutinib, an oral Bruton tyrosine kinase inhibitor, is a new treatment strategy for CNSL. This study aims to evaluate the efficacy and safety of orelabrutinib-based regimens in th
Autor:
Xiao Rui Fu, Xing Ai Wu, Zhen Chang Sun, Wang Ma, Fei Fei Nan, Qing Xia Fan, Li Geng, Mingzhi Zhang, Rui Lin Wang
Publikováno v:
Journal of proteomics. 72(6)
Serum samples from non-Hodgkin lymphoma (NHL) patients who had not undergone chemotherapy, lymphnoditis patients, and healthy adults were analyzed using surface-enhanced laser desorption-ionization time-of-flight mass spectrometry (SELDI-TOF MS) to d